Page last updated: 2024-10-25

dantrolene and Parkinsonian Disorders

dantrolene has been researched along with Parkinsonian Disorders in 2 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hirata, Y1
Ito, Y1
Takashima, M1
Yagyu, K1
Oh-Hashi, K1
Suzuki, H1
Ono, K1
Furuta, K1
Sawada, M1
Gaig, C1
Martí, MJ1
Tolosa, E1
Gómez-Choco, MJ1
Amaro, S1

Other Studies

2 other studies available for dantrolene and Parkinsonian Disorders

ArticleYear
Novel Oxindole-Curcumin Hybrid Compound for Antioxidative Stress and Neuroprotection.
    ACS chemical neuroscience, 2020, 01-02, Volume: 11, Issue:1

    Topics: Animals; Antioxidants; Cell Line; Curcumin; Dantrolene; Mice; Neurons; Neuroprotection; Neuroprotect

2020
Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave.
    Journal of neurology, 2005, Volume: 252, Issue:9

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever of Unk

2005